Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Serious Gram-positive Infections”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableEnded earlyNCT01290237
What this trial is testing

Use of a Loading Dose of Vancomycin in Pediatric Dosing

Who this might be right for
Infection
Boston Children's Hospital 59
Large-scale testing (Phase 3)Study completedNCT03164291
What this trial is testing

Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex

Who this might be right for
Nontuberculous Mycobacterial Infections
The University of Texas Health Science Center at Tyler 170
Not applicableStudy completedNCT00002085
What this trial is testing

Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV InfectionsTuberculosis, Mycobacterium Infection
Pfizer
Not applicableUnknownNCT01314053
What this trial is testing

Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections

Who this might be right for
Serious Gram-positive Infections
Taipei Medical University WanFang Hospital 60
Early research (Phase 1)Study completedNCT01791049
What this trial is testing

TD-1607 SAD Study in Healthy Subjects

Who this might be right for
Serious Infections Due to Known or Suspected Gram-positive Pathogens
Theravance Biopharma 64
Not applicableUnknownNCT01301638
What this trial is testing

Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections

Who this might be right for
BacteremiaEndocarditisSerious Gram-positive Infections
Far Eastern Memorial Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02052388
What this trial is testing

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Who this might be right for
Skin InfectionBacterial Infection
Cellceutix Corporation 215
Large-scale testing (Phase 3)Study completedNCT00079976
What this trial is testing

Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)

Who this might be right for
Gram-Positive Bacterial InfectionsStaphylococcus InfectionsVancomycin Resistance+1 more
Wyeth is now a wholly owned subsidiary of Pfizer 174